G. Busby

Integrating a Polygenic Risk Score for Coronary Artery Disease as a Risk Enhancing Factor in the Pooled Cohort Equation is Cost-effective in a US Health System

G. Figtree, D. Mujwara, G. Henno, 2021, medRxiv.

Integrating a Polygenic Risk Score for Coronary Artery Disease as a Risk‐Enhancing Factor in the Pooled Cohort Equation: A Cost‐Effectiveness Analysis Study

G. Figtree, B. Schroeder, G. Bottà, 2022, Journal of the American Heart Association.

Flexible and cost-effective genomic surveillance of P. falciparum malaria with targeted nanopore sequencing

Anna E. Jeffreys, Jason A Hendry, C. Drakeley, 2023, bioRxiv.

Genetic assessments of breast cancer risk that do not account for polygenic background are incomplete and lead to incorrect preventative strategies

N. Yousfi, G. Bottà, P. Di Domenico, 2021, medRxiv.

Polygenic Risk Score Modifies Risk of Coronary Artery Disease Conferred by Low-Density Lipoprotein Cholesterol

G. Bottà, R. Pastorino, P. Di Domenico, 2020, medRxiv.

Risk of Coronary Artery Disease Conferred by Low-Density Lipoprotein Cholesterol Depends on Polygenic Background

G. Bottà, R. Pastorino, P. Di Domenico, 2021, Circulation.

Cost-effectiveness analysis of implementing polygenic risk score in a workplace cardiovascular disease prevention program

G. Bottà, D. Mujwara, P. Di Domenico, 2023, Frontiers in public health.

Ancestry-specific polygenic risk scores are risk enhancers for clinical cardiovascular disease assessments

G. Bottà, G. Busby, S. Kulm, 2023, Nature communications.